Alongside, the homozygosity for the −866 G > A mutation in the promoter region of the uncoupling protein 2 (UCP2) gene protects against NASH, whereby enhancing hepatic UCP2 expression [226]. The gene discussed is UCP2; the disease is metabolic dysfunction-associated steatohepatitis.